Featured Insight
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
On-Demand Webinar – SDOH and EHR – How are EHR vendors enabling providers’ efforts to close care gaps attributable to SDOH?
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond
In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.
On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach
Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
White Paper: 2022 and Beyond: How Key Legislative Events Will Impact the Payer Landscape
Interested in learning more about several legislative events shaping the managed care landscape in 2022 and beyond? Check out this insightful white paper, based on our recent webinar, which features insights from PRECISIONvalue’s expert Access Experience Team on various legislative proposals and payers’ potential responses to regulatory changes.
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
PRECISIONvalue Named a Finalist in the Innovation Challenge Category of the Fierce Pharma Marketing Awards
We are excited to announce that PRECISIONvalue has been named a finalist in the Innovation Challenge category of the Fierce Pharma Marketing Awards.
Post-PHE Medicaid Disenrollment and Employer Group Enrollment Impact
With the end of the COVID-19 Public Health Emergency and national emergency on May 11, 2023, Medicaid state agencies have begun the process of redetermining which Medicaid participants may no longer be eligible and, consequently, dropped from Medicaid. Precision's Jorge Font addresses the potential impact to commercial/employer plan enrollment shifts resulting from the unwinding of Medicaid continuous coverage protection.
Care Delivery Changes and Challenges after the Public Health Emergency
As the Biden Administration looked to transition COVID-19 policies, including flexibilities enabled by the COVID-19 emergency declarations, into improving standards of care for patients, it allowed the Public Health Emergency (PHE) Act to expire on May 11, 2023. Precision's Christy Banach considers how the end of the PHE Act will impact care delivery and patient care now that certain provisions that allowed for expanded, easier access to care may or may not remain in place.
PRECISIONvalue ranked in MM+M’s Top 100 North American healthcare agencies of 2023
We're honored to announce that PRECISIONvalue ranked in MM+M's Top 100 North American healthcare agencies of 2023.
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Download Now: Precision May Events Calendar
The May Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Care Delivery Changes and Challenges after the Public Health Emergency
As the Biden Administration looked to transition COVID-19 policies, including flexibilities enabled by the COVID-19 emergency declarations, into improving standards of care for patients, it allowed the Public Health Emergency (PHE) Act to expire on May 11, 2023. Precision's Christy Banach considers how the end of the PHE Act will impact care delivery and patient care now that certain provisions that allowed for expanded, easier access to care may or may not remain in place.
PRECISIONvalue ranked in MM+M’s Top 100 North American healthcare agencies of 2023
We're honored to announce that PRECISIONvalue ranked in MM+M's Top 100 North American healthcare agencies of 2023.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers
As an increasing number of cell and gene therapies are US Food and Drug Administration approved, health care stakeholders are attempting to strike a balance between patient access to innovative treatments and overall affordability. Read about the survey by Precision's Erin Lopata, Christopher Terrone and Ami Gopalan to understand how access decision-makers and employers are using innovative financial models to support coverage of high-investment medications.
Price Controls and Competition
The Inflation Reduction Act will shift formulary development and contracting dynamics. Time for manufacturers to have a clear, persuasive value story. Learn more from PRECISIONvalue expert Erin Lopata.
The Evolution of Payer Access: Now and Then
Patients already look beyond their prescription benefits for ways to pay. The Inflation Reduction Act is likely to increase demand for new solutions. PRECISIONvalue Chief Medical Officer Dominic Galante explains why.
On-demand Webinar: Gene Therapies In Hemophilia
As the first ‘big wave’ in the gene therapy space, onetime potentially curative treatments for hemophilia present a potential revolution for many thousands of patients. Watch this on-demand webinar and Q&A moderated by Precision's Larry Blandford, as we explore these challenges, and discuss solutions to getting innovative therapies into the hands of patients who need them most.
On-demand Webinar: Using HEOR Methods to Reduce Health Inequalities
Current social and political events have brought renewed attention to the levels of systemic inequalities faced by millions of minorities in the United States and around the world. Moderated by Precision's Kelly Wilder, join us and learn how innovative health economics and outcomes research (HEOR) methods can be leveraged to quantify the full value new treatments that improve health outcomes for underserved communities.
